Semantic Scholar uses AI to extract papers important to this topic.
The standard treatment of HCV infection with pegylated interferon-alpha2a or -alpha2b and ribavirin is effective in <50% of HCV… Expand
The currently circulating H3N2 and H1N1 subtypes of influenza A virus cause a transient, febrile upper respiratory… Expand Liver disease secondary to chronic hepatitis C virus (HCV) infection is an important cause of morbidity and mortality in dialysis… Expand BACKGROUND/AIMS
Pegylated interferon plus ribavirin can cause dose-limiting anemia. Taribavirin, a ribavirin prodrug, has shown a… Expand Anemia is a common side effect that begins soon after the initiation of peginterferon/ribavirin in the treatment of hepatitis C… Expand Abstract: Chronic infection with hepatitis C virus (HCV) can progress to cirrhosis, hepatocellular carcinoma, and end‐stage liver… Expand Viramidine, the 3-carboxamidine derivative of ribavirin, was effective against a spectrum of influenza A (H1N1, H3N2 and H5N1… Expand Conventional interferon (IFN) alfa has been used for many years in the treatment of chronic hepatitis C. However, few patients… Expand Ribavirin, part of the current first line combination therapy for the treatment of chronic hepatitis C, may cause haemolytic… Expand Ribavirin, in combination with interferons, has proved clinically useful for the treatment of hepatitis C virus (HCV) infection… Expand